Product Information

BRIMONIDINE-TIMOLOL 0.2%-0.5% is a generic product labeled by Apotex Corp., priced at $2.7948 per ML under NDC 60505058901. Its NADAC has been published 194 times since Dec 7, 2022.

FDA first approved this application on Apr 20, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRIMONIDINE-TIMOLOL 0.2%-0.5%

Brimonidine Tartrate and Timolol Maleate
$2.7948per ML

Strength

2; 5 mg/mL; mg/mL

Manufacturer

Apotex Corp.

NDC

60505058901

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA091442

FDA Approved

4/20/2022

TE Code

AB

On Market Since

10/19/2022

Pharmacological Classes

Adrenergic alpha-Agonists
Adrenergic beta-Antagonists
alpha-Adrenergic Agonist
beta-Adrenergic Blocker

Price Statistics

The NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has been published 194 times since Dec 7, 2022, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7948 per ML
All-time high$30.1545 (Dec 14, 2022)
All-time low$2.7948 (Aug 19, 2026)
52-week high$4.7280
52-week low$2.7948
Median price$7.0873
Average price$10.1711
Largest weekly change-37.2% (Jul 17, 2024)
Weeks tracked194
Tracking sinceDec 7, 2022

Price History

1W

-1.4%

1M

-1.4%

3M

-10.7%

6M

-10.2%

1Y

-40.9%

3Y

-84.0%

5Y

N/A

All

-90.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRIMONIDINE-TIMOLOL 0.2%-0.5%?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE-TIMOLOL 0.2%-0.5%, manufactured by Apotex Corp., is $2.7948 per ML (NDC 60505058901), effective Aug 19, 2026.

How has the price of BRIMONIDINE-TIMOLOL 0.2%-0.5% changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has declined 90.7%. It has been tracked across 194 weekly CMS publications since Dec 7, 2022.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Since Dec 7, 2022, the NADAC for BRIMONIDINE-TIMOLOL 0.2%-0.5% has ranged from a low of $2.7948 (Aug 19, 2026) to a high of $30.1545 (Dec 14, 2022), with a median of $7.0873 per ML.

Are there cheaper alternatives to BRIMONIDINE-TIMOLOL 0.2%-0.5%?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE-TIMOLOL 0.2%-0.5%, is $1.8390 per ML — about 34% below BRIMONIDINE-TIMOLOL 0.2%-0.5%.

Who manufactures BRIMONIDINE-TIMOLOL 0.2%-0.5%?

BRIMONIDINE-TIMOLOL 0.2%-0.5% (NDC 60505058901) is labeled by Apotex Corp., and CMS classifies it as a generic product.